Study Details
Testing the Study Drug Cenobamate for People with Primary Generalized Tonic-Clonic Seizures
(IRB#: IRB_00151622)
Primary Generalized Tonic-Clonic (PGTC) Seizures is a disease that impacts a persons entire brain and causes loss of consciousness and muscle contractions. This study will test a drug called Cenobamate to treat people with PGTC. The study wants to see if the drug will help people and is safe. People in the study will be randomly chosen to be treated with Cenobamate or a placebo. A placebo looks like the drug but without the medication. Being in the study requires up to 15 study visits for about 37 weeks. Participants will write in a daily journal. Medical tests will be done during the study to track the health of participants.
- All genders
- Over 7 years old
- Volunteers with special conditions
- In Person
- Paid
Who can participate?
Gender: All genders
Age: Over 7 years old
Volunteers: Volunteers with special conditions
Location: In Person
Inclusion Criteria
- Ages 12 years and older
- Diagnosed with PGTC seizures
- Have had a routine electroencephalogram (recording of brain activity) within 5 years before participation
- Able to attend in person at the University of Utah study clinic
Exclusion Criteria
- Pregnant
- Hospitalization due to seizure within 12 months before participation
- Previously participated in Cenobamate clinical studies
- History of drug or alcohol dependency or abuse within 2 years before participation
Will I be paid for my time?
Yes
IRB#: IRB_00151622
PI: Matthew Sweney
Department: PEDIATRIC NEUROLOGY
Approval Date: 2023-10-04 06:00:00
Study Categories: Brain Health Studies
Specialties: Neurology
I am Interested